Taiwan FDA registration 9ae31ff561218a9ac451c8bdcb70aa1a

"Dengwei" Scar Care Tablets (Non-sterilized)

TW: "登偉" 疤痕護理片(未滅菌)

Taiwan·Risk Class 1·Alliance Pharmaceuticals Limited;; SCARPRO NV·Registered Aug 09, 2024 – Aug 09, 2029Active

Registration details

Analysis ID: 9ae31ff561218a9ac451c8bdcb70aa1a
Customs Code: DHA09402356407

Company information

Manufacturer: Alliance Pharmaceuticals Limited;; SCARPRO NV
Manufacturer Country: United Kingdom;;Belgium
Authorized Representative: GLORIA BIOMED CO., LTD.

Product details

Intended Use: It is limited to the scope of first-level identification of the "Silicone Products for Scar Treatment (I.4025)" of the Administrative Measures for the Classification and Grading of Medical Devices.
Product Type (Level 1): I General, Plastic Surgery and Dermatology
Product Type (Level 2): I.4025 Silicone products for scar treatment
Import Information: Input;; Contract manufacturing

Dates and status

Registration Date: Aug 09, 2024
Expiry Date: Aug 09, 2029

About this record

Access comprehensive regulatory information for "Dengwei" Scar Care Tablets (Non-sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 9ae31ff561218a9ac451c8bdcb70aa1a and manufactured by Alliance Pharmaceuticals Limited;; SCARPRO NV. The authorized representative in Taiwan is GLORIA BIOMED CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.